Roy C. Hardiman
CIK 1506218 · Chief Business & Strategy Ofcr · last filed 2026-01-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.14M
Companies
2
Total Filings
20
Lifetime Open-Market Net
-$1.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALMS | Chief Business & Strategy Ofcr | 212,818 | $24.15 | $5.14M | $0 | 4 | 2026-01-28 |
| Principia Biopharma Inc. (PRNB) Delisted | Chief Business Officer | 0 | — | — | -$1.30M | 7 | 2020-09-28 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-08 | Principia Biopharma Inc. (PRNB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-10-03 | — | Grant (A) | — | $0 | |
| 2012-07-05 | — | Grant (A) | — | $0 | |
| 2012-04-04 | — | Grant (A) | — | $0 | |
| 2012-01-05 | — | Grant (A) | — | $0 | |
| 2011-12-19 | — | Grant (A) | — | $0 | |
| 2011-10-05 | — | Grant (A) | — | $0 | |
| 2011-07-06 | — | Grant (A) | — | $0 | |
| 2011-04-05 | — | Grant (A) | — | $0 | |
| 2010-12-13 | — | Grant (A) | — | $0 |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.